Paul Tudor Jones’s Terns Pharmaceuticals TERN Stock Holding History

Paul Tudor Jones’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-267,520	Closed	-$14.1M	–	4264
2026 Q1	$14.1M	Buy	267,520 +194,274	+265%	+$7.98M	0.03%	572
2025 Q4	$2.96M	Buy	+73,246	New	+$1.69M	0.01%	1524
2024 Q4	–	Sell	-10,263	Closed	-$85.6K	–	3503
2024 Q3	$85.6K	Sell	10,263 -5,490	-35%	-$45.2K	﹤0.01%	2601
2024 Q2	$107K	Buy	+15,753	New	+$95.4K	﹤0.01%	2201

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Paul Tudor Jones's TERN Position: Q2 2026 in Review

Paul Tudor Jones sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 267,520 shares — an estimated $14.1M sold.

Paul Tudor Jones first reported a position in TERN in Q2 2024 and held it in 4 quarters. The position peaked at $14.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Paul Tudor Jones reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 267,520 Terns Pharmaceuticals shares in Q2 2026, an estimated $14.1M.
Paul Tudor Jones first reported a position in Terns Pharmaceuticals in Q2 2024 and held it in 4 quarters.
Paul Tudor Jones's Terns Pharmaceuticals position peaked at $14.1M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.